跳至主要内容
临床试验/CTRI/2024/02/062477
CTRI/2024/02/062477招募中4 期

Comparison of intravenous amisulpride and ondansetron for prevention of postoperative nausea and vomiting after gynaecological laparoscopy: a randomized clinical trial

Apollo Hospitals Bilaspur1 个研究点 分布在 1 个国家目标入组 80 人开始时间: 2024年2月15日最近更新:

试验速览

阶段
4 期
状态
招募中
入组人数
80
试验地点
1
主要终点
Incidence and severity of nausea and vomiting

研究概览

简要总结

Postoperative nausea and vomiting are common and problematic after general anesthesia in laparoscopic surgery. The incidence of PONV in gynecological surgery occurs at a rate of 40 to 75% even as high as 90%. PONV is associated with female gender, previous PONV, motion sickness, smoke free status and opioid use. The use of intravenous amisulpride for prevention of PONV in gynecological laparoscopic surgeries has not been explored. Amisulpride is a selective antagonist of dopamine D2 and D3 receptors. Therefore, the present study aimed to probe and investigate the effectiveness of intravenous amisulpride and ondansetron for prevention of PONV in laparoscopic surgery. All selected patients will be randomized in to two groups (40 patients in each group) depending on the drug used.

Group A- received intravenous amisulpride 5 mg diluted with 5 ml normal saline at the time of induction of anesthesia slowly over 2 minutes.

Group O - received intravenous ondansetron 4 mg diluted with 5 ml normal saline at the time of induction of anesthesia slowly over 2 minutes.

Primary outcome is incidence and severity of PONV experienced by each patient after surgery and recorded at following three assessment periods: 0-2 hr, 2-6 hr and 6-24 hr after surgery.

Secondary outcome is requirement of rescue antiemetic at same time interval and patient satisfaction score after 24 hr after surgery.

Statistical analysis will be done after completion of study.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
Participant, Investigator and Outcome Assessor Blinded

入排标准

年龄范围
20.00 Year(s) 至 60.00 Year(s)(—)
性别
Female

入选标准

  • ASA Grade I and II Scheduled for laparoscopic surgery under general anesthesia.

排除标准

  • Allergy to any drug involved in the study History of other antiemetic drug usage and motion sickness Morbid obesity Emergency surgery History of alcohol opioid and drug abuse Psychiatric and pregnant patients.

结局指标

主要结局

Incidence and severity of nausea and vomiting

时间窗: assessment periods: 0–2 hr, 2–6 hr and 6–24 h after surgery.

次要结局

  • Requirement of rescue antiemetic and patients satisfaction score(Assessment periods: 0–2 hr, 2–6 hr and 6–24 h after surgery.)

研究者

申办方类型
Research institution and hospital
责任方
Principal Investigator
主要研究者

DR VELLORE SRIKANTH HAMSA

Apollo Hospitals Bilaspur

研究点 (1)

Loading locations...

相似试验